Series date: 
01/03/2024 - 11:45am PST to 12/18/2024 - 1:15pm PST

Series Description: 

The interdisciplinary healthcare team will discuss NCCN and national standards while reviewing individual breast oncology cases to create appropriate individualized Breast Cancer treatment care plans with collaboration of the entire care team. Case study review allows the interdisciplinary team to discuss in real time clinical cases to develop individualized care plans for hard to solve cases. In addition to the discussion of current data and recommendations for clinical trial participation.

Target Audience: 

Nurse Practitioner (NP)

Nurse, Registered (RN)

Physicians (MD or DO)

Other Healthcare Professionals

Learning Objectives- After Attending this Activity, Learners Should be Able to:

1. Prioritize interprofessional collaboration during review of difficult and unique patient cases in order gain consensus and achieve an informed decision on the ideal treatment plan recommendations for each patient presented at the Breast Tumor Board utilizing evidence-based guidelines (i.e., NCCN).

2. Identify appropriate candidates for clinical trial participation based on critical analysis of emerging evidence and discussion of current patient-level data.

3. Apply best practice recommendations in the practice of clinical staging documentation.

4. Discuss what matters most to patients and families in order to engage in and support shared decision-making discussions with the patient and family about palliative care preferences, genetic testing, or smoking cessation as applicable.

5. Demonstrate cultural humility in the ability to deliver culturally appropriate care, free of implicit biases, for families of diverse cultural backgrounds and belief systems. This includes learning from the patients and families directly about how they perceive health and illness as well as respond to various diseases, symptoms, and treatments.

Accreditation

In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation Statement

Sutter Health designates this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™  for physicians, 1.00 continuing professional development contact hours for nurses, and 1.00 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Note to Other DisciplinesAMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.

 

Attendance & Credit Claiming

Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.

Sessions

Session Date
0260_ABSMC_Breast Tumor Board_RSS_2024 - 08/14/24 08/14/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 08/21/24 08/21/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 08/28/24 08/28/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 09/04/24 09/04/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 09/11/24 09/11/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 09/18/24 09/18/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 09/25/24 09/25/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 10/02/24 10/02/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 10/09/24 10/09/2024 - 12:00pm to 1:00pm PDT
0260_ABSMC_Breast Tumor Board_RSS_2024 - 10/16/24 10/16/2024 - 12:00pm to 1:00pm PDT

Pages